Make your money go further for just 25p per day

PREMIUM

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Alphabet (GOOGL)  · Apple (AAPL)  · AstraZeneca (AZN)  · GSK (GSK)  · Novartis (NOVN)  · Nvidia (NVDA)  · Uber Technologies (UBER) 

UK US

Image in style of Monet illustrating AI

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors as we consider here, with three sectors set to be big winners. 


Remember to listen to Episode 24 of the Investor’s Champion Podcast

In this episode of the Investors Champion podcast, hosts Chris and Lee focus on the world of small caps and AIM. Topics include a discussion of YouGov’s profit warning, the contrasting fortunes of AIM’s cosmetics companies, a bizarre franchise creation and Supreme’s strange acquisition. Other companies covered include, Intercede, Chapel Down, Gear4Music, Time Finance, and PCI PAL. The episode also touches on notable market activities…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alphabet

Ultimate Stocks Portfolio: encouraging updates lift shares

25/11/2024 · Portfolio

Plenty of news from our high-quality companies with our UK stars the standout performers here and…


Episode 39 of the Investor’s Champion Podcast

23/11/2024 · Podcasts

In this episode of the Investors Champion Podcast, hosts Chris and Lee dive into the controversial…


More on Apple

Game delights | Consumer facing weakness | Tech delivers

02/08/2024 · Portfolio

Most of our Ultimate Stocks continue to deliver excellent results although it’s more of a struggle…


Ultimate Stocks portfolio: company news

19/07/2024 · Portfolio

The CEO of one of our portfolio companies has clearly caught the football bug, paying a…


More on AstraZeneca

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…


More on GSK

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on Novartis

Overhyped perhaps - but don’t ignore AI!

03/07/2024 · Company Insights

Is AI overhyped? Of course it is, but there are still plenty of opportunities for investors…


Mega-Trends: A troubling 2021 opens opportunities for recovery

11/02/2022 · Portfolio

Sign-up to our free email updates

SIGN UP